Tickers

FRME — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-24 06:49:15.154060 UTC · finished 2026-09-24 06:52:22.732985 UTC

1. Composite Trajectory Verdict

For a community banking franchise, the income statement and balance sheet carry roughly equal weight: earnings reflect the net interest margin and credit-cost cycle, while the balance sheet shows capital adequacy, asset quality, and funding stability.

Composite Trajectory: Mixed

The annual income statement shows a mixed trend: net income available to common stockholders fell from $221.9 million (2023) to $199.5 million (2024) then recovered to $224.1 million (2025), with diluted EPS following a similar V-shaped path ($3.73 → $3.41 → $3.88) (10-K 2025-12-31, Consolidated Statements of Operations). Net interest margin compressed from 3.35% to 3.19% before edging up to 3.25%, and the efficiency ratio improved to 53.55% in 2024 but slipped back to 54.54% in 2025 (10-K 2025-12-31, Financial Highlights). By contrast, the balance sheet trajectory is improving: tangible common equity to tangible assets rose from 8.40% to 8.81% to 9.38%, total loans grew 10.5% over two years to $13.8 billion, and all regulatory capital ratios strengthened (CET1 11.35% → 11.43% → 11.70%) (10-K 2025-12-31, Financial Highlights; Capital). Operating cash flow increased steadily from $258.8 million to $266.2 million to $283.6 million (10-K 2025-12-31, Consolidated Statements of Cash Flows). Quarterly trends cannot be assessed because the 10-Q financial statements are not provided in the filings.

2. Red Flags

  • Provision for credit losses spiked to $35.7 million in 2024 from $3.5 million in 2023, driven by $42.7 million of charge-offs on two commercial and industrial relationships, then declined to $21.3 million in 2025 but remained well above the 2023 level (10-K 2025-12-31, Results of Operations - 2024; Financial Highlights).
  • Net charge-offs as a percentage of average loans jumped to 0.39% in 2024 from 0.21% in 2023 before falling to 0.14% in 2025 (10-K 2025-12-31, Financial Highlights).
  • Nonperforming assets to total assets rose from 0.32% (2023) to 0.43% (2024) and only partially retreated to 0.38% (2025) (10-K 2025-12-31, Financial Highlights).
  • Net interest margin (FTE) declined 16 basis points from 2023 to 2024 and recovered only 6 basis points in 2025, remaining below the 2023 level (3.35% → 3.19% → 3.25%) (10-K 2025-12-31, Financial Highlights).
  • Efficiency ratio (non-GAAP) improved to 53.55% in 2024 but deteriorated to 54.54% in 2025 (10-K 2025-12-31, Financial Highlights).
  • Accumulated other comprehensive loss remained substantial at -$130.1 million (2025) and -$188.7 million (2024), driven by unrealized losses on available-for-sale securities (10-K 2025-12-31, Consolidated Balance Sheets).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: Net income available to common stockholders followed a V-shaped pattern over the three annual periods, declining 10.1% from $221.9 million (2023) to $199.5 million (2024) then rising 12.3% to $224.1 million (2025) (10-K 2025-12-31, Consolidated Statements of Operations). Diluted EPS moved from $3.73 to $3.41 to $3.88 over the same span (10-K 2025-12-31, Consolidated Statements of Operations). Net interest income dipped from $545.4 million to $521.1 million before recovering to $536.0 million (10-K 2025-12-31, Financial Highlights). Noninterest income grew consistently from $105.6 million to $125.6 million to $126.9 million (10-K 2025-12-31, Financial Highlights). Noninterest expense fell from $388.3 million to $379.3 million then ticked up to $382.6 million (10-K 2025-12-31, Financial Highlights). The provision for credit losses surged to $35.7 million in 2024 from $3.5 million in 2023, then moderated to $21.3 million in 2025 (10-K 2025-12-31, Financial Highlights). Return on average assets fell from 1.23% to 1.09% then rose to 1.21%; return on average equity fell from 10.43% to 8.86% then rose to 9.43% (10-K 2025-12-31, Financial Highlights).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Overall Assessment: Net cash provided by operating activities increased in each of the three reported years: $258.8 million (2023) → $266.2 million (2024) → $283.6 million (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows). The excess of operating cash flow over net income persisted and widened slightly: $35.0 million (2023), $64.8 million (2024), $57.6 million (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows; Consolidated Statements of Operations). Investing and financing cash flows reflect balance sheet management (loan growth, securities portfolio repositioning, deposit flows, borrowings, and share repurchases) but operating cash generation shows a clear upward trend across the annual periods.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Overall Assessment: Total assets grew 3.4% over the two-year span, from $18.4 billion (2023) to $19.0 billion (2025), with total loans expanding 10.5% from $12.5 billion to $13.8 billion (10-K 2025-12-31, Financial Highlights). Total deposits declined 2.0% to $14.5 billion in 2024 then rose 5.3% to $15.3 billion in 2025 (10-K 2025-12-31, Financial Highlights). Total borrowings peaked at $1.16 billion in 2024 and fell to $1.00 billion in 2025 (10-K 2025-12-31, Financial Highlights). Total stockholders' equity increased steadily from $2.25 billion to $2.30 billion to $2.47 billion (10-K 2025-12-31, Financial Highlights). The equity-to-assets ratio improved from 12.21% to 12.59% to 12.97%, and tangible common equity to tangible assets rose from 8.40% to 8.81% to 9.38% (10-K 2025-12-31, Financial Highlights). All regulatory capital ratios strengthened: CET1 from 11.35% to 11.43% to 11.70%, Tier 1 leverage from 9.64% to 9.96% to 10.24% (10-K 2025-12-31, Financial Highlights). The allowance for credit losses to total loans declined from 1.64% to 1.50% to 1.42% while coverage of nonaccrual loans remained above 260% (10-K 2025-12-31, Financial Highlights).

6. Data Gaps

  • Quarterly income statements (revenue, expenses, net income, EPS) for Q2 2025, Q3 2025, Q1 2026, Q2 2026 — not provided in the 10-Q excerpts.
  • Quarterly balance sheets (loans, deposits, borrowings, equity, capital ratios) for the same quarters — not provided.
  • Quarterly cash flow statements (operating, investing, financing) for the same quarters — not provided.
  • Quarterly net interest margin, efficiency ratio, and credit quality metrics (NPLs, charge-offs, provision) — not provided.
  • Year-over-year quarterly comparisons (e.g., Q2 2026 vs. Q2 2025) — cannot be computed without the quarterly financial statements.
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status